Gideon Capital Advisors’s Exact Sciences EXAS Stock Holding History

Gideon Capital Advisors’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-5,786	Closed	-$501K	–	320
2019 Q1	$501K	Buy	+5,786	New	+$492K	0.18%	168
2018 Q3	–	Sell	-4,048	Closed	-$242K	–	394
2018 Q2	$242K	Sell	4,048 -11,317	-74%	-$609K	0.12%	302
2018 Q1	$620K	Buy	+15,365	New	+$750K	0.38%	73
2017 Q3	–	Sell	-7,386	Closed	-$261K	–	305
2017 Q2	$261K	Buy	+7,386	New	+$228K	0.29%	159

Other funds holding EXAS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Gideon Capital Advisors's EXAS Position: Q2 2019 in Review

Gideon Capital Advisors sold out of Exact Sciences (EXAS) in Q2 2019, closing a stake of 5,786 shares — an estimated $501K sold.

Gideon Capital Advisors first reported a position in EXAS in Q2 2017 and held it in 4 quarters. The position peaked at $620K in Q1 2018. 472 funds tracked by Wall St. Rank hold EXAS as of Q2 2019.

Gideon Capital Advisors reported no remaining Exact Sciences position as of Q2 2019 after selling out during the quarter.
Gideon Capital Advisors sold 5,786 Exact Sciences shares in Q2 2019, an estimated $501K.
Gideon Capital Advisors first reported a position in Exact Sciences in Q2 2017 and held it in 4 quarters.
Gideon Capital Advisors's Exact Sciences position peaked at $620K in Q1 2018.
472 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2019.

Based on Gideon Capital Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.